Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune

  • Post date May 8, 2022 — 15:37 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

002422 002486 300322 300568 Fortune Ng Fung Food Guotai Junan Securities Huizhou Speed Wireless Technology Jiangsu Hengrui Medicine Shanghai Challenge Textile Company Limited Shanghai Fosun Pharmaceutical Shenzhen Senior Technology Material Sichuan Kelun Pharmaceutical Xiamen Amoytop Biotech Zhejiang Huahai Pharmaceutical Witness Accounting, Audit Layoffs, Downsizing Management Annual, Special Corporate Meeting Annual Report Research, Development Health, Beauty Product Pharmaceutical Gold, Precious Material Credit, Debt Market, Exchange Securities Stocks Cancer Epidemic Hospital Medicine Therapy Workplace Health, Safety Food, Drink Enthusiasm Small, Medium Enterprise Oncology Midsummer Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data